The role of metals in the etiology of Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 11, Issue 2, 2007, Pages 191-205

  Shcherbatykh, Ivan ^a,b   Carpenter, David O ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Aluminum; Alzheimer's disease; Copper; Fluoride; Iron; Mercury; Neurodegenerative diseases; Silica; Transition metals; Zinc

Indexed keywords

ALUMINUM; COPPER; DRINKING WATER; FLUORIDE; IRON; METAL; SILICON DIOXIDE; ZINC;

ALZHEIMER DISEASE; DEGENERATIVE DISEASE; DEMENTIA; DISEASE COURSE; ECONOMIC ASPECT; ENVIRONMENTAL FACTOR; HEMODIALYSIS; HUMAN; NERVE CELL; NEUROFIBRILLARY TANGLE; NEUROPROTECTION; NONHUMAN; NUTRITION; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; WORLD HEALTH ORGANIZATION;

EID: 34347332411     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2007-11207     Document Type: Review

References (139)

1. M. Ahlqwist, C. Bengtsson, L. Laipus, I.A. Gergdahl and A. Schutz, Serum mercury concentration in relation to survival, symptoms and disease: results from a prospective population study of women in Gothenburg, Sweden, Acta Odontl Scand 57 (1999), 168-174.
2. A.C. Alfrey, Aluminum and renal disease, in: Moving Points in Nephrology, Vol. 102, E. Bourke, N.P. Mallick, and V.E. Pollak, eds, Contrib Nephrol Basel, Karger, 1993, pp. 110-124.
3. A.C. Alfrey, G.R. LeGendre and W.D. Kaehny, The dialysis encephalopathy syndrome: Possible aluminum intoxication, N Engl J Med 294 (1976), 184 -188.
4. C.S. Atwood, X. Huang, R.D. Moir, R.E. Tanzi and A.I. Bush, Role of free radicals and metal ions in the pathogenesis of Alzheimer's disease, Metal Ions Biol Syst 36 (1999), 309-364.
5. L. Balazs and M. Leon, Evidence of an oxidative challenge in Alzheimer's brain, Neurochem Res 19 (1990), 1131-1137.
6. C. Bancher, H. Lassmann, H. Breitschopf and K.A. Jellinger, Mechanisms of cell death in Alzheimer's disease, J Neural Transm 50 (1997), 141-152.
7. W.A. Banks, M.L. Niehoff, D. Drago and P. Zatta, Aluminum complexing enhances amyloid β protein penetration of blood-brain barrier, Brain Res 1116 (2006), 215-221.
8. A. Becaria, D.K. Lahiri, S.C. Bondy, D. Chen, A. Hamadeh, H. Li, R. Taylor and A. Campbell, Aluminum and copper in drinking water enhance inflammatory or oxidative events specifically in the brain, J Neuroimmunol 176 (2006), 16-23.
9. M. Belles, D.J. Sanchez, M. Gomez, J. Corbella and J.L. Domingo, Silicon reduces aluminum accumulation in rats: relevance to the aluminum hypothesis of Alzheimer's disease, Alzheimer Dis Assoc Disord 12 (1998), 83-87.
10. J.D. Birchall, The interrelationship between silicon and aluminum in the biological effects of aluminum, in: Aluminum in Biology and Medicine, (Ciba Foundation Symposium no. 169), Wiley, Chichester, 1992, pp. 50-68.
11. J.D. Birchall and J.S. Chappell, Aluminum, chemical physiology, and Alzheimer' disease, Lancet 2 (1988), 1008-1010.
12. L. Bjorkman, N.N.L. Pedersen and P. Lichtenstein, Physical and mental health related to dental amalgam fillings in Swedish twins, Comm Dent Oral Epidemiol 24 (1996), 260-267.
13. G.A. Broe, A.S. Henderson, H. Creasey, E. McCusker, A.E. Korten, A.F. Jorm, W. Longley and J.C. Anthony, A casecontrol study of Alzheimer's disease in Australia, Neurology 40 (1990), 1698-1707.
14. R. Brookmeyer, S. Gray and C. Kawas, Projections of Alzheimer's disease in the USA and the public health impact of delaying disease onset, Am J Public Health 88 (1998), 1337-1342.
15. A.M. Brown, D.M. Tummolo, K.J. Rhodes, J.R. Hofmann, J.S. Jacobsen and J. Sonnenberg-Reines, Selective aggregation of endogenous b-amyloid peptide and soluble amyloid precursor protein in cerebrospinal fluid by zinc, J Neurochem 69 (1997), 1204-1212.
16. F.M. Burnet, A possible role of zinc in the pathology of dementia, Lancet 1 (1981), 186-188.
17. A.I. Bush, Metals and neuroscience, Curr Opin Chem Biol 4 (2000), 184-191.
18. A.I. Bush, The metallobiology of Alzheimer's disease, Trends in Neurosci 26 (2003), 207-214.
19. A.I. Bush, C.L. Masters and R.E. Tanzi, Copper, beta-amyloid, and Alzheimer's disease: tapping a sensitive connection, Proc Natl Acad Sci USA 100 (2003), 11193-11194.
20. Canadian Study of Health and Aging, The Canadian Study of Health and Aging: Risk factors for Alzheimer's disease in Canada, Neurology 44 (1994), 2073-2080.
21. J.M. Candy, F.K. McArthur, A.E. Oakley, G.A. Taylor, C.P. Chen, S.A. Mountfort, J.E. Thompson, P.R. Chalker, H.E. Bishop, K. Beyreuther, G. Perry, M.K. Ward, C.N. Martyn and J.A. Edwardson, Aluminum accumulation in relation to senile plaque and neurofibrillary tangle formation in the brains of patients with renal failure, J Neurol Sci 107 (1992), 210-218.
22. R.A. Cherny, C.S. Atwood, M.E. Xilinas, D.N. Gray, W.D. Jones, C.A. McLean, K.J. Barnham, I. Volitakis, F.W. Fraser, Y. Kim, X. Huang, L.E. Goldstein, R.D. Moir, J.T. Lim, K. Beyreuther, H. Zheng, R.E. Tanzi, C.L. Masters and A.I. Bush, Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice, Neuron 30 (2001), 665-676.
23. R.A. Cherny, J.T.Legg, C.A. McLean, D.P. Fairlie, X. Huang, C.S. Atwood, K. Beyreuther, R.E. Tanzi, C.L. Masters and A.I. Bush, Aqueous dissolution of Alzheimer's disease A beta amyloid deposits by biometal depletion, J Biol Chem 274 (1999), 23223-23228.
24. 12, and serum total homocysteine levels in confirmed Alzheimer's disease, Arch Neurol 55 (1998), 1449-1455.
25. T.W. Clarkson, The three modern faces of mercury, Environ Health Perspect 110 (2002), 11-23.
26. J. Constantinidis, The hypothesis of zinc deficiency in the pathogenesis of neurofibrillary tangles, Med Hypoth 35 (1991), 319-323.
27. C.R. Cornett, W.R. Markesbery and W.D. Ehmann, Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain, NeuroToxicology 19 (1998), 339-345.
28. F.M. Corrigan, G.P. Reynolds and N.I. Ward, Hippocampal tin, aluminum and zinc in Alzheimer's disease, Biometals 6 (1993), 149-154.
29. J.T.Coyle and P. Puttfarcken, Oxidative stress, glutamate and neurodegenerative disorders, Science 262 (1993), 689-695.
30. D.R. Crapper, S.S. Krishnan and A.J. Dalton, Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration, Science 180 (1973), 511-513.
31. M.P. Cuajungco, L.E. Goldstein, A. Nunomura, M.A. Smith, J.T. Lim, C.S. Atwood, X. Huang, Y.W. Farrag, G. Perry and A.I. Bush, Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of Aβ by zinc, J Biol Chem 275 (2000), 19439-19442.
32. M.P. Cuajungco and G.J. Lees, Zinc and Alzheimer's disease: is there a direct link? Brain Res 799 (1997), 97-107.
33. M.P. Cuajungco and G.J. Lees, Zinc metabolism in the brain: relevance to human neurodegenerative disorders, Neurobiol Dis 4 (1997), 137-169.
34. J.L. Cummings, H.V. Vinters, G.M. Cole and Z.S. Khachaturian, Alzheimer's disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities, Neurology 51 (1998), S2-S7.
35. M.A. Deibel, W.D. Ehmann and W.R. Markesbery, Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress, J Neurol Sci 143 (1996), 137-142.
36. R. Doll, Review: Alzheimer's disease and environmental aluminum, Age Ageing 22 (1993), 138-153.
37. V. Döllken, Über die Wirkung des Aluminiums mit besonderer Berücksichtigung der durch das Aluminium verursachten Läsionen im Zentralnervensystem, Arch Exp Pathol Pharmacol (1897), 98-120.
38. C.L. Emsley, S. Gao, Y. Li, C. Liang, R. Ji, K.S. Hall, J. Cao, F. Ma, Y. Wu, P. Ying, Y. Zhang, S. Sun, F.W. Unverzagt, C.W. Slemenda and H.C. Hendrie, Trace element levels in drinking water and cognitive function among elderly Chinese, Am J Epidemiol 151 (2000), 913-920.
39. R.L. Emst and J.W. Hay, The US economical and social costs of Alzheimer's disease revisited, Am J Public Health 84 (1994), 1261-1264.
40. J.L. Esparza, M. Gómez, M. Romeu, M. Mulero, D.J. Sánchez, J. Mallol and J.L. Domingo, Aluminum-induced pro-oxidant effects in rats: protective role of exogenous melatonin, J Pineal Res 35 (2003), 32-39.
41. D.A. Evans, L.E. Hebert, L.A. Beckett, P.A. Scherr, M.S. Albert, M.J. Chown, D.M. Pilgrim and J.O. Taylor, Education and other measures of socioeconomic status and risk of incident Alzheimer's disease in a defined population of older persons, Arch Neurol 54 (1997), 1399-1405.
42. 42 in senile plaque cores in Alzheimer's disease, J Alzheimer Disord 10 (2006), 173-177.
43. C. Exley, E. Burgess, J.P. Day, E.H. Jeffery, S. Melethil and R.A. Yokel, Aluminum toxicokinetics, J Toxicol Environ Health 48 (1996), 569-584.
44. C. Exley and M.M. Esiri, Severe cerebral congophilic angiopathy coincident with increased brain aluminum in a resident of Camelford, Cornwall, UK, J Neurol Neurosurg Psychiatry 77 (2006), 877-879.
45. T.P. Flaten, Aluminum as a risk factor in Alzheimer's disease, with emphasis on drinking water, Brain Res Bull 55 (2001), 187-196.
46. T.P. Flaten, Geographical associations between aluminum in drinking water and death rates with dementia (including Alzheimer's disease), Parkinson's disease and amyotrophic lateral sclerosis in Norway, Environ Geochem Health 12 (1990), 152-167.
47. W.F. Forbes, J.F. Gentleman and N. Agwani, Geochemical risk factors for mental functioning, based on the Ontario Longitudinal Study of Aging (LSA) VI. The effects of iron on the associations of aluminum and fluoride water concentrations and of pH with mental functioning, based on results obtained from the LSA and from death certificates mentioning dementia, Can J Aging 16 (1997), 142-159.
48. W.F. Forbes, L.M. Hayward and N. Agwani, Geochemical risk factors for mental functioning, based on the Ontario Longitudinal Study of Aging (LSA) I. Results from a preliminary investigation, Can J Aging 11 (1992), 269-280.
49. W.F. Forbes, S. Lessard and J.F. Gentleman, Geochemical risk factors for mental functioning, based on the Ontario Longitudinal Study of Aging (LSA) V. Comparisons of the results, relevant to aluminum water concentrations, obtained from the LSA and from death certificates mentioning dementia, Can J Aging 14 (1995), 642-656.
50. W.F. Forbes, C.A. McAiney, L.M. Hayward and N. Agwani, Geochemical risk factors for mental functioning, based on the Ontario Longitudinal Study of Aging (LSA) II. The role of pH, Can J Aging 13 (1994), 249-267.
51. D.P. Forster, A.J. Newens, D.W.K. Kay and J.A. Edwardson, Risk factors in clinically diagnosed presenile dementia of the Alzheimer's type: A case-control study in northern England, J Epidemiol Comm Health 49 (1995), 253-258.
52. L. Fratiglioni, A. Ahlbom, M. Viitanen and B.Winblad, Risk factors for late-onset Alzheimer's disease, Ann Neurol 33 (1993), 258-266.
53. M.F. Frecker, Dementia in Newfoundland: Identification of a geographical isolate? J Epidemiol Community Health 45 (1991), 307-311.
54. R.M. Garruto and P. Brown, Tau protein, aluminum, and Alzheimer's disease, Lancet 343 (1994), 989-999.
55. E. Gauthier, I. Fortier, F. Courchesne, P. Pepin, J. Mortimer and D. Gauvreau, Aluminum forms in drinking water and risk of Alzheimer's disease, Environ Res 84 (2000), 234-246.
56. B.J. Gurland, D.E. Wilder, R. Lantigua, Y. Stern, J. Chen, E.H. Killeffer and R. Mayeux, Rates of dementia in three ethnoracial groups, Int J Geriatr Psychiatry 14 (1999), 481-493.
57. A. Haug, B. Shi and V. Vitorello, Aluminum interaction with phosphoinositide-associated signal transduction, Arch Toxicol 68 (1994), 1-7.
58. C. Helmer, P. Joly, L. Letenneur, D. Commenges and J.F. Dartigues, Mortality with dementia: results from a French prospective community-based cohort, Am J Epidemiol 154 (2001), 642-648.
59. A.B. Hill, The environment and disease: association or causation? Proc R Soc Med 58 (1965), 295-300.
60. X. Huang, C.S. Atwood, M.A. Hartshorn, G. Multhaup, L.E. Goldstein, R.C. Scarpa, M.P. Cuajungco, D.N. Gray, J. Lim, R.D. Moir, R.E. Tanzi and A.I Bush, The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction, Biochemistry 38 (1999), 7609-7616.
61. X. Huang, M.P. Cuajungco, C.S. Atwood, M.A. Hartshorn, J.D. Tyndall, G.R. Hanson, K.C. Stokes, M. Leopold, G. Multhaup, L.E. Goldstein, R.C. Scarpa, A.J Saunders, J. Lim, R.D. Moir, C. Glabe, E.F.Bowden, C.L. Masters, D.P Fairlie, R.E. Tanzi and A.I. Bush, Cu (II) potentiation of Alzheimer's Aβ neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction, J Biol Chem 274 (1999), 37111-37116.
62. X. Huang, R.D. Moir, R.E. Tanzi, A.I. Bush and J. T. Rogers, Redox-active metals, oxidative stress, and Alzheimer's disease pathology, Ann NY Acad Sci 1012 (2004), 153-163.
63. H. Jacqmin, D. Commenges, L. Letenneur, P. Barberger-Gateau and J.-F. Dartigues, Components of drinking water and risk of cognitive impairment in the elderly, Am J Epidemiol 139 (1994), 48-57.
64. H. Jacqmin-Gadda, D. Commenges, L. Letenneur and J.-F. Dartigues, Silica and aluminum in drinking water and cognitive impairment in the elderly, Epidemiology 7 (1996), 281-285.
65. R. Jugdaohsingh, D.M. Reffitt, C. Oldham, J.P. Day, L.K. Fifield, R.P. Thompson and J.J. Powell, Oligomeric but not monomeric silica prevents aluminum absorption in humans, Am J Clin Nutr 71 (2000), 944-949.
66. S. Kalmijn, L.J. Launer, A. Ott, J.C. Witteman, A. Hofman and M.M. Breteler, Dietary fat intake and the risk of incident dementia in the Rotterdam study, Ann Neurol 42 (1997), 776-782.
67. I. Klatzo, H.Wisniewski and E. Streicher, Experimental production of neurofibrillary degeneration. I. Light microscopic observations, J Neuropathol Exp Neurol 24 (1965), 187-199.
68. T. Kowalik-Jankowska, M. Ruta-Dolejsz, K. Wisniewska, L. Lankiewicz and H. Kozlowski, Possible involvement of copper (II) in Alzheimer's disease, Environ Health Perspect 110 (2002), 869-870.
69. L.J. Launer, K. Andersen, M.E. Dewey, L. Letenneur, A. Ott, L.A. Amaducci, C. Brayne, J.R. Copeland, J.F. Dartigues, P. Kragh-Sorensen, A. Lobo, J.M. Martinez-Lage, T. Stijnen and A. Hofman, Rates and risk factors for dementia and Alzheimer's disease, Neurology 52 (1999), 78-84.
70. J.Y. Lee, T.B. Cole, R.D. Palmiter, S.W. Suh and J.Y. Koh, Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice, Proc Natl Acad Sci USA 99 (2002), 7705-7710.
71. 3+-induced aggregation, Neurochem Res 23 (1998), 1467-1476.
72. J. Lindsay, D. Laurin, R. Verreault, R. Hébert, B. Helliwell, G.B. Hill and I. McDowell, Risk factors for Alzheimer's disease: a prospective analysis from the Canadian study of health and aging, Am J Epidemiol 156 (2002), 445-453.
73. M.A. Lovell, J.D. Robertson, W.J. Teesdale, J.L. Campbell and W.R. Markesbery, Copper, iron and zinc in Alzheimer's disease senile plaques, J Neurol Sci 158 (1998), 47-52.
74. P.W. Mantyh, J.R. Ghilardi, S. Rogers, E. DeMaster, C.J. Allen, E.R. Stimson and J.E. Maggio, Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of b-amyloid peptide, J Neurochem 61 (1993), 1171-1174.
75. W.R. Markesbery and W.D. Ehmann, Brain trace elements in Alzheimer's disease, in: Alzheimer's Disease, R.D. Terry, R. Katzman and K.L. Bick, eds, Raven Press, New York, 1993, pp. 353-367.
76. C.N. Martyn, D.N. Coggon, H. Inskip, R.F. Lacey and W.F. Young, Aluminum concentration in drinking water and risk of Alzheimer's disease, Epidemiology 8 (1997), 281-286.
77. C.N. Martyn, C. Osmond, J.A. Edwardson, D.J.P. Barker, E.C. Harris and R.F. Lacey, Geographical relation between Alzheimer's disease and aluminum in drinking water, Lancet 333 (1989), 61-62.
78. W. Max, The economical impact of Alzheimer's disease, Neurology 43 (1993), S6-S10.
79. C.J. Maynard, R. Cappai, I. Volitakis, R.A. Cherny, A.R. White, K. Beyreuther, C.L. Masters, A.I. Bush and Q.X. Li, Over expression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron, J Biol Chem 277 (2002), 44670-44676.
80. D.R.C. McLachlan, Aluminum and the risk for Alzheimer's disease, Environmetrics 6 (1995), 233-275.
81. D.R.C. McLachlan, C. Bergeron, J.E. Smith, D. Boomer and S.L. Rifat, Risk for neuropathologically confirmed Alzheimer's disease and residual aluminum in municipal drinking water employing weighted residential histories, Neurology 46 (1996), 401-405.
82. P. Michel, D. Commenges, J.F. Dartigues, M. Gagnon, P. Barberger-Gateau and L. Letenneur, Study of the relationship between aluminum concentration in drinking water and risk of Alzheimer's disease, in: Alzheimer's Disease: Basic Mechanisms, Diagnosis and Therapeutic Strategies, K. Iqbal, D.R.C. McLachlan, B. Winblad and H.M. Wisniewski, H. M., eds, John Wiley & Sons, Chichester, 1991, pp. 387-391.
83. G. Miessler and D. Tarr, Inorganic Chemistry, Prentice Hall, 2003, 720.
84. J.A. Molina, F.J. Jimenez-Jimenez, M.V. Aguilar, I. Meseguer, C.J. Mateos-Vega, M.J. Gonzalez-Munoz, F. de Bustos, J. Porta, M. Orti-Pareja, M. Zurdo, E. Barrios and M.C. Martinez-Para, Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease, J Neural Transm 105 (1998), 479-488.
85. M.C. Morris, D.A. Evans, C.C. Tangney, J.L. Bienias, J.A. Schneider, R.S. Wilson and P.A. Scherr, Dietary copper and high saturated and trans fat intakes associated with cognitive decline, Arch Neurol 63 (2006), 1085-1088.
86. M.C. Morris, J.A. Schneider and C.C. Tangney, Thoughts on B-vitamins and dementia, J Alzheimers Disord 9 (2006), 429-433.
87. G. Multhaup, A. Schlicksupp, L. Hesse, D. Beher, T. Ruppert, C.L. Masters and K. Beyreuther, The amyloid precursor protein of Alzheimer's disease in the reduction of copper (II) to copper (I), Science 271 (1996)£< 1406-1409.
88. L.C. Neri and D. Hewitt, Aluminum, Alzheimer's disease, and drinking water, Lancet 338 (1991)£< 390.
89. R.L. Neve and N.K. Robakis, Alzheimer's disease: a reexamination of the amyloid hypothesis, TINS 21 (1998), 15-19.
90. E. Nieboer, B.L. Gibson, A.D. Oxman and J.R. Kramer, Health effects of aluminum: A critical review with emphasis on aluminum in drinking water, Environ Rev 3 (1995), 29-81.
91. A. Ogunniyi, O. Baiyewu, O. Gureje, K.S. Hall, F. Unverzagt, S.H. Siu, S. Gao, M. Farlow, O.S. Oluwole, O. Komolafe and H.C. Hendrie, Epidemiology of dementia in Nigeria: results from the Indianapolis-Ibadan study, Eur J Neurol 7 (2000), 485-490.
92. A.M. Palmer and M.A. Burns, Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease, Neurosci Lett 112 (1994), 333-337.
93. A.E. Panayi, N.M. Spyrou, B.S. Iversen, M.A. White and P. Part, Determination of cadmium and zinc in Alzheimer's brain tissue using inductively coupled plasma mass spectrometry, J Neuro Sci 195 (2002), 1-10.
94. J.A.T. Pennington, Aluminum content of foods and diets, Food Addit Contam 5 (1987), 161-232.
95. J.A.T. Pennington and S.A. Schoen, Estimates of dietary exposure to aluminum, Food Addit Contam 12 (1995), 119-128.
96. D. Pratico, K. Uryu, S. Sung, S. Tang, J.Q. Trojanowski and V.M. Lee, Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice, FASEB J 16 (2002), 1138-1140.
97. D. Religa, D. Strozyk, R.A. Cherny, I. Volitakis, V. Haroutunian, B.Winblad, J. Naslund and A.I. Bush, Elevated cortical zinc in Alzheimer's disease, Neurology 67 (2006), 69-75.
98. S.L. Rifat, M.R. Eastwood, D.R.C. McLachlan and P.N. Corey, Effect of exposure of miners to aluminum powder, Lancet 336 (1990), 1162-1165.
99. M.A.M. Rogers and D.G. Simon, A preliminary study of dietary aluminum intake and risk of Alzheimer's disease, Age Ageing 28 (1999), 205-209.
100. H.B. Röllin, P. Theodorou and T.A. Kilroe-Smith, The effect of exposure to aluminum on concentrations of essential metals in serum of foundry workers, Br J Ind Med 48 (1991), 243-246.
101. V. Rondeau, D. Commenges, H. Jacqmin-Gadda and J.-F. Dartigues, Relation between aluminum concentrations in drinking water and Alzheimer's disease: An 8-year followup study, Am J Epidemiol 152 (2000), 59-66.
102. R.N. Rosenberg, The molecular and genetic basis of Alzheimer's disease, Neurology 54 (2000), 2045-2054.
103. G.W. Ross, H. Petrovitch, L.R. White, K.H. Masaki, C.Y. Li, J.D. Curb, K. Yano, B.L. Rodriguez, D.J. Foley, P.L. Blanchette and R. Havlik, Characterization of risk factors for vascular dementia: the Honolulu-Asia aging study, Neurology 53 (1999), 337-343.
104. W. Roush, Protein studies try to puzzle out Alzheimer's tangles, Science 267 (1995), 793-794.
105. F.H. Ruiz, M. Gonzalez, M. Bodini, C. Opazo and N.C. Inestrosa, Cysteine 144 is a key residue in the copper reduction by the beta-amyloid precursor protein, J Neurochem 73 (1999), 1288-1292.
106. L.L. Rulon, J.D. Robertson, M.A. Lovell, M.A. Deibel, W.D. Ehmann and W.R. Markesber, Serum zinc levels and Alzheimer's disease, Biol Trace Elem Res 75 (2000), 79-85.
107. S.M. Saiyed and R.A. Yokel, Aluminum content of some foods and food products in the USA, with aluminum food additives, Food Addit Contam 22 (2005), 234-244.
108. S. Seshadri, D.A. Drachman and C.F. Lippa, Apolipoprotein E4 and the lifetime risk of Alzheimer's disease, Arch Neurol 52 (1995), 1074-1079.
109. S. Seshadri, P.A. Wolf, A. Beiser, R. Au, K. McNulty, R. White and R.B. D'Agostino, Lifetime risk of dementia and Alzheimer's disease. The impact of mortality on risk estimates in the Framingham Study, Neurology 49 (1997), 1498-1504.
110. M.-F. Shadlen, W.C. McCormick and E.B. Larson, Research agenda for understanding Alzheimer's disease in diverse populations: work group on cultural diversity, Alzheimer's association, Alzheimer Dis Assoc Disord 16 (2002), S96-S100.
111. R.-W. Shin, W.M.-Y. Lee and J.Q. Trojanowski, Aluminum modifies the properties of Alzheimer's disease PHFτ proteins in vivo and in vitro, J Neurosci 14 (1994), 7221-7233.
112. A.J. Slooter, M. Cruts, S. Kalmijn, A. Hofman, M.M. Breteler, C. Van Broeckhoven and C.M. van Duijn, Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam study, Arch Neurol 55 (1998), 964-968.
113. L.F. Smith, Public health role, aluminum and Alzheimer's disease, Environmetrics 6 (1995), 277-286.
114. M.A. Smith, K. Hirai, K. Hsiao, M.A. Pappolla, P.L. Harris, S.L. Siedlak, M. Tabaton and G. Perry, Amyloid-beta deposition in Alzheimer's transgenic mice is associated with oxidative stress, J Neurochem 70 (1998), 2212-2215.
115. D.L. Sparks and B.G. Schreurs, Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease, Proc Natl Acad Sci USA 100 (2003), 11065-11069.
116. H. Spencer, L. Kramer, C. Norris and E. Wiatrowski, Effect of aluminum hydroxide on plasma fluoride and fluoride excretion during a high fluoride intake in man, Toxicol Appl Pharmacol 58 (1981), 140-144.
117. R. Squitti, P.M. Rossini, E. Cassetta, F. Moffa, P. Pasqualetti, M. Cortesi, A. Colloca, L. Rossi and A. Finazzi-Agro, D-penicillamine reduces serum oxidative stress in Alzheimer's disease patients, Eur J Clin Invest 32 (2002), 51-59.
118. Statement on use of apolipoprotein E testing for Alzheimer's disease. American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer's Disease, JAMA 274 (1995), 1627-1629.
119. C.N. Still and P. Kelley, On the incidence of primary degenerative dementia vs. water fluoride content in South Carolina, NeuroToxicology 1 (1980), 125-131.
120. M.J. Strong, Aluminum neurotoxicity: an experimental approach to the induction of neurofilamentous inclusions, J Neurol Sci 124 (1994), 20-26.
121. K.V. Subbarao, J.S. Richardson and L.C. Ang, Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro, J Neurochem 55 (1990), 1594-1601.
122. Y.-H. Suh and F. Checler, Amyloid precursor protein, presenilins, and -synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease, Pharmacol Rev 54 (2002), 469-525.
123. M.X. Tang, P. Cross, H. Andrews, D.M. Jacobs, S. Small, K. Bell, C. Merchant, R. Lantigua, R. Costa, Y. Stern and R. Mayeux, Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan, Neurology 56 (2001), 49-56.
124. G.A. Taylor, A.J. Newens, J.A. Edwardson, D.W.K. Kay and D.P. Forster, Alzheimer's disease and the relationship between silicon and aluminum in water supplies in northern England, J Epidemiol Comm Health 49 (1995), 323-324.
125. R.D.Terry and C. Peña, Experimental production of neurofibrillary degeneration. 2. Electron microscopy, phosphatase histochemistry and electron probe analysis, J Neuropathol Exp Neurol 24 (1964), 200-210.
126. C.M. Thompson, W.R. Markesbery, W.D. Ehmann, Y.X. Mao and D.E. Vance, Regional brain trace element studies in Alzheimer's disease, NeuroToxicology 9 (1988), 1-7.
127. J. Tuneva, S. Chittur, A.A. Boldyrev, I. Birman and D.O. Carpenter, Cerebellar granule cell death induced by aluminum, Neurotox Res 9 (2006), 1-8.
128. J.C. Vickers, T.C. Dickson, P.A. Adlard, H.L. Saunders, C.E. King and G. McCormack, The cause of neuronal degeneration in Alzheimer's disease, Prog Neurobiol 60 (1999), 139-165.
129. T. Vogt, Water quality and health: Study of a possible relation between aluminum in drinking water and dementia, Sosiale og Økonomiske Studier, 61, Oslo: Statistics Norway, 1986.
130. E.M. Von Strauss, D. Viitanen, D. De Ronchi, B. Winblad and L. Fratiglioni, Aging and the occurrence of dementia, Arch Neurol 56 (1999), 587-592.
131. A. Wettstein, J. Aeppli, K. Gautschi and M. Peters, Failure to find a relationship between mnestic skills of octogenarians and aluminum in drinking water, Int Arch Occup Environ Health 63 (1991), 97-103.
132. L. White, H. Petrovitch, G.W. Ross, K.H. Masaki, R.D. Abbott, E.L. Teng, B.L. Rodriguez, P.L. Blanchette, R.J Havlik, G. Wergowske, D. Chiu, D.J. Foley, C. Murdaugh and J.D. Curb, Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study, JAMA 276 (1996), 955-960.
133. R.R. Wills and J. Savory, Aluminum poisoning: Dialysis encephalopathy, osteomalacia and anaemia, Lancet 2 (1983), 29-34.
134. C. Wolfson, D.B. Wolfson, M. Asgharian, C.E M'Lan, T. Ostbye, K. Rockwood, D.B. Hogan, Clinical Progression of Dementia Study Group, A reevaluation of the duration of survival after the onset of dementia, NEngl J Med 344 (2001), 1111-1116.
135. M.H.Wong, K.F. Fung and H.P. Carr, Aluminum and fluoride contents of tea, with emphasis on brick tea and their health implications, Toxicol Lett 137 (2003), 111-120.
136. D.J. Wood, C. Cooper, J. Stevens and J. Edwardson, Bone mass and dementia in hip fracture patients from areas with different aluminium concentrations in water supplies, Age Ageing 17 (1988), 415-419.
137. World Health Organization (WHO)/IPCS, Aluminum, Environ. Health Criteria 194 (1997), 1-152. WHO, Geneva.
138. R.A. Yokel, Blood-brain barrier flux of aluminum, manganese, iron and other metals suspected to contribute to metal-induced neurodegeneration, J Alzheimer Disord 10 (2006), 223-253.
139. R.A. Yokel and R.L. Florence, Aluminum bioavailability from the approved food additive leavening agent acidic sodium aluminum phosphate, incorporated into a baked good, is lower than from water, Toxicology 227 (2006), 86-93.